Advertisement
Screener

Haemonetics Corporation (HAE) Contract Liability (Deferred Revenue)

2.8 / 5 stars · 68/120 Roast Me

Haemonetics Corporation Contract Liability (Deferred Revenue)

Haemonetics Corporation (HAE) had Contract Liability (Deferred Revenue) of $42.31 million as of 2026-03-28, per its 10-K filed 2026-05-20.

Financial Statements › Balance Sheet › Liabilities › Liabilities, Current

us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2026-05-20

  • 2026-03-28: Contract with Customer, Liability, Current $42.31M.
  • 2025-03-29: Contract with Customer, Liability, Current $43.35M.
  • 2024-03-30: Contract with Customer, Liability, Current $31.24M.
  • 2023-04-01: Contract with Customer, Liability, Current $30.21M.
Period endContract with Customer, Liability, Current
2026-03-28$42.31M
10-K · filed 2026-05-20
2025-03-29$43.35M
10-K · filed 2026-05-20
2024-03-30$31.24M
10-K · filed 2025-05-21
2023-04-01$30.21M
10-K · filed 2024-05-20
2022-04-02$26.81M
10-K · filed 2023-05-22

Similar stocks

Stock NameCountryMarket CapPE Ratio
TELEFLEX INC (TFX)United States$5.093B-5.44
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44
Heartflow, Inc. (HTFL)United States$4.225B
ICU MEDICAL INC/DE (ICUI)United States$4.153B18.85
MiniMed Group, Inc. (MMED)United States$5.748B-16.85
PULSE BIOSCIENCES, INC. (PLSE)United States$3.696B-24.47
iRhythm Holdings, Inc. (IRTC)United States$3.651B-281.06
AtriCure, Inc. (ATRC)United States$3.089B
UFP TECHNOLOGIES INC (UFPT)United States$2.308B28.37
Inspire Medical Systems, Inc. (INSP)United States$1.990B9.55